Company intelligence / Profile preview

RPG Global

Mumbai, Maharashtra, India

Ownership: Private
Development stage: Other

Overview

RPG Life Sciences manufactures commercial pharmaceuticals, APIs, and biosimilars in India and exports globally. The company is a leader in immunosuppressants and has developed IP for novel microemulsion cyclosporine and several niche APIs. Clinical results for key products like cyclosporine have been described as satisfactory and the company has achieved strong market share in India for several products[4][7][1].

Therapeutic areas: NephrologyCardiovascularImmunologyEndocrinologyGastroenterologyInfectious DiseasesPsychiatryOncology
Modalities: Small moleculeBiologicBiosimilarPeptidesAntibody (for select biosimilar products)
Industry: Biotech

Partnerships

Intas Pharma (biotech business sale partner[2])Multiple international marketing/license partners (not individually named)

Beyond the preview

Go deeper on RPG Global.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RPG Global.

Explore the full profile